LF
Lee Financial Portfolio holdings
AUM
$697M
1-Year Return
15.8%
This Quarter Return
+3.92%
1 Year Return
+15.8%
3 Year Return
+55.74%
5 Year Return
+99.49%
10 Year Return
–
AUM
$583M
AUM Growth
-$3.22M
(-0.55%)
Cap. Flow
-$23.7M
Cap. Flow
% of AUM
-4.07%
Top 10 Holdings %
Top 10 Hldgs %
58.6%
Holding
1,002
New
73
Increased
127
Reduced
302
Closed
214
Top Buys
| 1 |
iShares Short Treasury Bond ETF
SHV
|
+$17.5M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$8.07M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.96M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$1.45M |
| 5 |
Home Depot
HD
|
+$1.17M |
Top Sells
| 1 |
Schwab Fundamental International Large Company Index ETF
FNDF
|
+$12.3M |
| 2 |
Apple
AAPL
|
+$7.18M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.16M |
| 4 |
Energy Transfer Partners
ET
|
+$1.57M |
| 5 |
VanEck Oil Services ETF
OIH
|
+$1.22M |
Sector Composition
| 1 | Financials | 6.17% |
| 2 | Technology | 5.16% |
| 3 | Energy | 2.23% |
| 4 | Healthcare | 1.44% |
| 5 | Consumer Staples | 1.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Federal Signal
FSS
$7.59B
| $15.5K | ﹤0.01% |
285
-70
| -20% | -$3.8K |
|
352
CDW
CDW
$22B
| $15.4K | ﹤0.01% |
79
| – | – |
|
353
Bio-Rad Laboratories Class A
BIO
$7.86B
| $15.3K | ﹤0.01% |
32
| – | – |
|
354
Neurocrine Biosciences
NBIX
$14.3B
| $15.2K | ﹤0.01% |
150
-10
| -6% | -$1.01K |
|
355
Entegris
ENTG
$12.4B
| $15.2K | ﹤0.01% |
185
-4
| -2% | -$328 |
|
356
Idacorp
IDA
$6.68B
| $15.2K | ﹤0.01% |
140
| – | – |
|
357
Hexcel
HXL
$5.12B
| $15K | ﹤0.01% |
220
| – | – |
|
358
Exponent
EXPO
$3.59B
| $15K | ﹤0.01% |
150
+20
| +15% | +$1.99K |
|
359
Quaker Houghton
KWR
$2.5B
| $14.6K | ﹤0.01% |
74
| – | – |
|
360
MGM Resorts International
MGM
$9.85B
| $14.5K | ﹤0.01% |
327
-4,081
| -93% | -$181K |
|
361
Integer Holdings
ITGR
$3.72B
| $14.3K | ﹤0.01% |
185
+30
| +19% | +$2.33K |
|
362
Marathon Petroleum
MPC
$55.1B
| $14.3K | ﹤0.01% |
106
-2,005
| -95% | -$270K |
|
363
Elevance Health
ELV
$69.4B
| $14.3K | ﹤0.01% |
31
-5
| -14% | -$2.3K |
|
|
ITCI
364
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $14.1K | ﹤0.01% |
260
+40
| +18% | +$2.17K |
|
365
Consolidated Edison
ED
$34.9B
| $14.1K | ﹤0.01% |
147
-5
| -3% | -$478 |
|
366
Blackrock
BLK
$171B
| $14.1K | ﹤0.01% |
21
+15
| +250% | +$10K |
|
367
Lowe's Companies
LOW
$153B
| $14K | ﹤0.01% |
70
+11
| +19% | +$2.2K |
|
368
Agree Realty
ADC
$8.04B
| $13.7K | ﹤0.01% |
200
| – | – |
|
369
Pinnacle Financial Partners
PNFP
$7.63B
| $13.5K | ﹤0.01% |
245
| – | – |
|
370
iShares Morningstar Small-Cap Growth ETF
ISCG
$730M
| $13.5K | ﹤0.01% |
346
+1
| +0.3% | +$39 |
|
371
EastGroup Properties
EGP
$8.91B
| $13.2K | ﹤0.01% |
80
| – | – |
|
372
Acadia Healthcare
ACHC
$2.08B
| $13K | ﹤0.01% |
180
| – | – |
|
373
Dorman Products
DORM
$5.08B
| $12.9K | ﹤0.01% |
150
| – | – |
|
374
Pultegroup
PHM
$27.9B
| $12.9K | ﹤0.01% |
220
| – | – |
|
375
GSK
GSK
$80.6B
| $12.8K | ﹤0.01% |
360
| – | – |
|